The medical device company ZYLOXTB (02190) has announced the execution of a share repurchase. On June 23, the company utilized approximately HK$4.4 million to buy back 243,000 of its own shares from the open market.
This transaction represents a strategic move by the company to return value to its shareholders and reflects management's confidence in the firm's long-term prospects and intrinsic value.